Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03633110
Title Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genocea Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica California 90404 United States Details
University of Colorado, Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
Columbia University Medical Center - Herbert Irving Pavilion New York New York 10032 United States Details
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
The Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field